Double agent: how Escherichia coli switches from commensal to pathogen in the urinary tract infection
- 1University of Campania Luigi Vanvitelli ’ and AORN Ospedali dei Colli-Monaldi Hospital, Naples, Italy
- 2Institute for Biotechnology, Brandenburg University of Technology, Senftenberg, Germany
Abstract
Escherichia coli exhibits a dual nature as both a beneficial gut commensal and the predominant cause of community-acquired urinary tract infections (UTIs) worldwide. This review synthesizes current evidence establishing phenotypic plasticity the capacity for dynamic, non-heritable, and reversible adaptation as a central determinant of uropathogenic E. coli pathogenesis, distinct from stable genetic resistance. From a multilayered perspective, a comprehensive analysis is provided of how genomic diversity, host-pathogen interactions at the bladder epithelium, and exposure to clinically relevant antibiotics collectively drive morphological and regulatory reprogramming. These adaptations include surface roughening, filamentation, and RpoS-mediated persistence, along with (p)ppGpp stringent response and EnvZ/OmpR two-component system signaling, which enhance bacterial survival independently of genetic resistance mutations. The review further discusses how these mechanisms establish a coordinated survival matrix, creating a fundamental disconnect between standard antibiotic susceptibility testing and the host-associated phenotypes that characterize actual infections. Unlike genetically resistant bacteria that grow at elevated antibiotic concentrations, phenotypically tolerant cells exhibit normal MICs but require prolonged killing times, explaining why recurrent UTIs occur despite appropriate therapy. Finally, recent advances, including phage vB_EcoP_P64441 combined with cefotaxime for biofilm disruption, glucose-mediated gentamicin tolerance targeting metabolic pathways, and HDAC inhibitors such as valproic acid for host-directed epigenetic reprogramming, offer new opportunities to break the debilitating cycle of recurrent UTIs affecting millions worldwide.
Related
- Isolation, identification, and slow-growth phenotype characterization of a clinically derived Escherichia coli from urinary tract infection
- Parvimonas micra and central nervous system infections: mechanisms of transformation from oral commensal to intracranial pathogen and clinical evidence.
- Detection of high-risk sequence type ST131 among multidrug-resistant Escherichia coli causing urinary tract infections in Cusco, Peru
- Ceftazidime-avibactam activity against urinary carbapenem resistance Escherichia coli and Klebsiella pneumoniae isolates
- Temporal Comparison of Virulence-Associated Characteristics and Metabolic Activity in Fluoroquinolone-Resistant Escherichia coli O25 ST131 Urinary Isolates from Croatia.
BibTeX
@article{gul2026double,
title = {{Double agent: how Escherichia coli switches from commensal to pathogen in the urinary tract infection}},
author = {Sabiha Gul},
journal = {Infection},
year = {2026},
month = jul,
doi = {10.1007/s15010-026-02872-1},
url = {https://doi.org/10.1007/s15010-026-02872-1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Double agent: how Escherichia coli switches from commensal to pathogen in the urinary tract infection
AU - Sabiha Gul
PY - 2026
DA - 2026/07/03
JO - Infection
DO - 10.1007/s15010-026-02872-1
UR - https://doi.org/10.1007/s15010-026-02872-1
AB - Escherichia coli exhibits a dual nature as both a beneficial gut commensal and the predominant cause of community-acquired urinary tract infections (UTIs) worldwide. This review synthesizes current evidence establishing phenotypic plasticity the capacity for dynamic, non-heritable, and reversible adaptation as a central determinant of uropathogenic E. coli pathogenesis, distinct from stable genetic resistance. From a multilayered perspective, a comprehensive analysis is provided of how genomic diversity, host-pathogen interactions at the bladder epithelium, and exposure to clinically relevant antibiotics collectively drive morphological and regulatory reprogramming. These adaptations include surface roughening, filamentation, and RpoS-mediated persistence, along with (p)ppGpp stringent response and EnvZ/OmpR two-component system signaling, which enhance bacterial survival independently of genetic resistance mutations. The review further discusses how these mechanisms establish a coordinated survival matrix, creating a fundamental disconnect between standard antibiotic susceptibility testing and the host-associated phenotypes that characterize actual infections. Unlike genetically resistant bacteria that grow at elevated antibiotic concentrations, phenotypically tolerant cells exhibit normal MICs but require prolonged killing times, explaining why recurrent UTIs occur despite appropriate therapy. Finally, recent advances, including phage vB_EcoP_P64441 combined with cefotaxime for biofilm disruption, glucose-mediated gentamicin tolerance targeting metabolic pathways, and HDAC inhibitors such as valproic acid for host-directed epigenetic reprogramming, offer new opportunities to break the debilitating cycle of recurrent UTIs affecting millions worldwide.
SN - 0300-8126
SN - 1439-0973
ER -